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Abstract
The self-renewal and differentiation capacities of human pluripotent stem cells (hPSCs)
make them a promising source of material for cell transplantation therapy, drug develop-
ment, and studies of cellular differentiation and development. However, the large numbers
of cells necessary for many of these applications require extensive expansion of hPSC cul-
tures, a process that has been associated with genetic and epigenetic alterations. We have
performed a combinatorial study on both hESCs and hiPSCs to compare the effects of en-
zymatic vs. mechanical passaging, and feeder-free vs. mouse embryonic fibroblast feeder
substrate, on the genetic and epigenetic stability and the phenotypic characteristics of
hPSCs. In extensive experiments involving over 100 continuous passages, we observed
that both enzymatic passaging and feeder-free culture were associated with genetic insta-
bility, higher rates of cell proliferation, and persistence of OCT4/POU5F1-positive cells in
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teratomas, with enzymatic passaging having the stronger effect. In all combinations of cul-
ture conditions except for mechanical passaging on feeder layers, we noted recurrent dele-
tions in the genomic region containing the tumor suppressor gene TP53, which was
associated with decreased mRNA expression of TP53, as well as alterations in the expres-
sion of several downstream genes consistent with a decrease in the activity of the TP53
pathway. Among the hESC cultures, we also observed culture-associated variations in
global gene expression and DNA methylation. The effects of enzymatic passaging and
feeder-free conditions were also observed in hiPSC cultures. Our results highlight the need
for careful assessment of the effects of culture conditions on cells intended for
clinical therapies.
Introduction
Human pluripotent stem cells (hPSCs, which include human embryonic stem cells (hESCs)
and human induced pluripotent stem cells (hiPSCs)) hold great promise for clinical applica-
tions. Their tremendous self-renewal and differentiation capacities make them potential
sources of large quantities of differentiated cells for drug screening, toxicology studies, biomol-
ecule production, and cell therapy.
Perhaps the biggest area of concern in stem cell-based clinical transplantation is the possi-
bility that the transplanted cells may be tumorigenic [1]. Since genetic and epigenetic instability
have been strongly associated with cancers, it is reasonable to assume that such instability is
undesirable in cell preparations destined for clinical use.
Large-scale genomic studies have revealed that both hESCs and hiPSCs accumulate sub-
chromosomal genetic changes that are not detectable by karyotyping [2–6]. Much attention
has been paid to the recurrent aberrations that have been found in multiple hPSC lines, includ-
ing subchromosomal duplications on chromosomes 12 and 20, which are of particular interest-
ed because the chromosome 12 duplications frequently contain the pluripotency-associated
NANOG gene and/or NANOGP1 (one of its pseudogenes), and the chromosome 20 duplica-
tion has been found to impart increased cell survival due to increased expression of Bcl-xL
[7,8]. However, many sporadic genetic aberrations have been observed in only hPSC line, and
the phenotypes of such aberrations have not been characterized.
Several small studies have indicated that time in culture or culture conditions may affect the
genetic [9–11] or epigenetic [10] stability of hPSCs, suggesting that it will be important to fu-
ture clinical applications to develop culture conditions that minimize acquisition of such ab-
normalities. Here, we report the first large-scale, systematic study of the potential effects of
multiple culture conditions, including culture substrate, medium type, passaging method, and
time in culture on the genetic, epigenetic and phenotypic stability of hPSCs.
Materials and Methods
Cell Culture
The HDF51iPS1, HDF51iPS7, and HDF51iPS11 lines were three independent hiPSC clones re-
programmed from human fetal dermal fibroblasts using the standard reprogramming factors
(OCT4/POU5F1, SOX2, KLF4, and MYC) carried by retroviral vectors [3,12]. WA09 is an
hESC line derived by the Thomson laboratory [13], and was obtained directly fromWiCell Re-
search Institute. WA09, HDF51iPS1, HDF51iPS7, and HDF51iPS11 cells were cultured at 37°C
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and 5% CO2 on extracellular matrix (Geltrex; Life Technologies) or irradiated mouse embryon-
ic fibroblasts (MEFs). Cells on feeder layers were cultured in standard hPSC medium, consist-
ing of Dulbecco’s modified eagle medium DMEM/F12 (Life Technologies) with 20% Knockout
Serum Replacement (Life Technologies), 1 mM GlutaMAX (Life Technologies), 0.1 mM non-
essential amino acids (NEAA, Life Technologies), and 12 ng/ml basic FGF (Life Technologies)
and passaged mechanically (MefMech) by cutting colonies into small pieces with a 18G needle
or enzymatically dissociated (MefEnz) with Accutase (Life Technologies). Cells cultured on
Geltrex in StemPro hESC SFM (Life Technologies) with 0.1 mM β-mercaptoethanol (Life
Technologies) and 12 ng/ml basic FGF (Life Technologies), were passaged mechanically (Ecm-
Mech) or enzymatically (EcmEnz) with Accutase. Cells on feeder layers were passaged once a
week and feeder-free cultures were passaged every three to four days. At each passage, 150,000
cells were seeded per well of a 6-well plate (equivalent to a cell plating density of ~15,600 cells/
cm2). To accurately count the number of cells in mechanically passaged cultures, the clumps of
cells were collected and gently triturated, and an aliquot was removed and completely dissoci-
ated to single cell suspension using Accutase. The medium was changed daily.
In transitioning the original cell cultures from the MefMech condition into the other condi-
tions, we started counting the passages in the new condition as soon as the process of transition
started. For transitioning frommechanical to enzymatic passaging, we simply started using
Accutase (Life Technologies). For transitioning from the Mef condition (which included culture
on mouse embryonic fibroblast feeder layers with the standard hPSC medium) to the Ecm con-
dition (which included culture on Geltrex (Life Technologies) with StemPro hESC SFM (Life
Technologies)), we initially passaged onto Geltrex (Life Technologies) using a 1:1 mixture of
standard hPSC medium:StemPro hESC SFM for 24 hours, followed by a 1:3 mixture of standard
hPSC medium:StemPro hESC SFM for 24 hours, and then 100% StemPro hESC SFM thereafter.
Teratoma formation, histopathologic evaluation and
immunohistochemistry
All procedures were done following the National Institute of Health (NIH) Guide for the Care
and Use of Laboratory Animals and were approved by the Scripps Research Institute and
UCSD Institutional Animal Care and Use Committees (IACUCs). For the teratoma assays, we
injected two mice per replicate (12 mice per culture condition) at two sites per mouse (1 testis
capsule and 1 leg injection). WA09 hESCs were harvested by Accutase (Life Technologies),
washed with PBS (Life Technologies), re-suspended in 30 μl of a 1:1 mixture of DMEM/F12
(Life Technologies) and Matrigel (BD Biosciences), and placed on ice. One million cells were
injected per site into the right testis capsule and left lower leg muscle of CB-17-Prkdcscid mice
(Charles River) with a 1cc syringe and a 27G, ½ inch needle. The injection site was monitored
for tumor growth weekly and six to eight weeks after injection the mice were euthanized and
the tumors removed. The tumors were measured, weighed, and fixed with PBS containing 4%
paraformaldehyde (Sigma-Aldrich). The specimens were sectioned and stained with hematox-
ylin and eosin and evaluated microscopically by a board-certified anatomic pathologist (MP)
to detect derivatives of the three germ layers. Selected sections were stained with a rabbit anti-
OCT4 primary antibody (Abcam, Cat # ab19857) at 1:400, using a Ventana Discovery Ultra au-
tomated immunostainer (Ventana Medical Systems) with standard antigen retrieval and re-
agents per the manufacturer’s protocol.
Karyotyping
Karyotyping was performed only on selected MefEnz cultures. Cell Line Genetics performed
G-banded karyotyping on the hESC cultures. 30 spreads were counted per culture.
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Mycoplasma Testing
Supernatant of the cultures was collected and mycoplasma was tested monthly using the Lonza
Luminescence test (Lonza) and VenorGeM PRC Test (Sigma-Aldrich) according to the
manufacturers’ protocols.
In Vitro Differentiation
For embryoid body (EB) formation, WA09 hESCs were harvested manually and transferred to
low attachment plates in Dulbecco’s modified eagle medium DMEM/F12 with 20% Knockout
Serum Replacement, 1 mM Glutamax, 0.1 mM non-essential amino acids (NEAA), 0.1 mM
β-mercaptoethanol. The cells were cultured in suspension for 7 days to allow for EB formation
and the media was changed every other day. On the eighth day, the EBs were transferred to gel-
atin (Life Technologies) coated coverslips with DMEM (Life Technologies), 2 mM Glutamax,
20% fetal bovine serum (Life Technologies), and 0.1 mM NEAA, and cultured seven more days
changing the medium every other day. EBs were then washed with PBS and fixed for 15 min-
utes with PBS containing 4% paraformaldehyde.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS for 15 minutes at room temperature. After
washing with PBS, the cells were treated with blocking solution (2% BSA (Sigma-Aldrich),
0.1% Triton X-100 (Sigma-Aldrich), and 2% low fat milk in PBS) for one hour at room temper-
ature. Primary antibodies include OCT4 (1:100, Santa Cruz); SSEA-4 (1:200, R&D system);
SOX2 (1:100, Millipore); TUJ1 (1:15,000, Millipore); Brachyury (1:300, Santa Cruz); Smooth
Muscle Actin (SMA) (1:2000, Millipore); alpha-fetoprotein (AFP) (1:400, Millipore). Fluores-
cent dye-labeled goat anti mouse, goat anti rat or donkey anti mouse was used as the secondary
antibody (Life Technology, Molecular Probes).
EDU Incorporation Assay
Cells were incubated with 20 μM EdU (Life Technologies) for 1 hour at 37°C, harvested,
washed with 1% BSA in PBS, and fixed in suspension for 15 minutes at room temperature with
4% paraformaldehyde. Cells were washed again, permeabilized with Triton X-100 for 30 min-
utes at room temperature, washed again, and incubated with the Click-iT EDU CellCycle
633-red (Life Technologies) for 30 minutes at room temperature and protected from light. The
samples were then analyzed by flow cytometry.
MTT Assay
Cells cultured on a 96-well plate were incubated in medium containing 0.4 mg/mL
3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide (MTT; TCI America) at
37°C for 1 h. Reduced MTT was solubilized in DMSO (Sigma-Aldrich) for determination of
absorbance at 570 nm.
Apoptosis Assay
Apoptosis rate was measured using the In Situ Cell Death Detection Kit (Roche). Cells were
harvested and a cell suspension of 106 cells/ 100 μl was fixed with 4% paraformaldehyde for
60 min at room temperature with shaking, washed with PBS, and permeabilized with 0.1% Tri-
ton X-100 in 0.1% sodium citrate (Sigma-Aldrich) for 2 minutes on ice. The labeling of DNA
strand breaks was performed for 60 minutes at 37°C by Terminal deoxynucleotidyltransferase
(TdT), which catalyzes polymerization of fluorescein labeled dUTP to free 3’-OH DNA ends in
Genetic and Epigenetic Instability in Human Embryonic Stem Cells
PLOS ONE | DOI:10.1371/journal.pone.0118307 February 25, 2015 4 / 25
a template independent manner, also known as TUNEL reaction. The cells were then washed
with PBS and analyzed by flow cytometry at an excitation wavelength of 488 nm and detection
at 515–565 nm.
Telomere Length Assay
Telomere length was measured using TeloTAGGG Telomere length assay (Roche). Cells were
harvested and genomic DNA was isolated with DNeasy Blood & Tissue kit (Qiagen). The con-
centration of genomic DNA was measured with the Qubit Quantitation Platform (Invitrogen),
the DNA concentration for each sample was normalized, and 1.5 μg of genomic DNA from the
sample or control DNA was digested with 40 units of Hinf I (New England Biolabs) and Rsa I
(New England Biolabs) for 2 hours at 37°C. The digestion was stopped with gel electrophoresis
loading buffer and the digested DNA was separated by 0.8% agarose gel electrophoresis. For
Southern blots, the digested DNA was transferred to a positively charged nylon membrane
(Roche) using capillary transfer. The DNA was fixed on the wet blotting membrane by UV-
crosslinking at 120 mJ. The blotted DNA fragments were then hybridized to a digoxigenin
(DIG)-labeled probe specific for telomeric repeats for 3 hours at 42°C, washed several times,
and incubated for 30 minutes at room temperature with a DIG-specific antibody covalently
coupled to alkaline phosphatase. The membrane was incubated with the chemiluminescent
substrate CDP-Star and imaged (Gel Doc XR System, Bio-Rad). The mean terminal restriction
fragment (TRF) length, which comprises the variable terminal array and the subtelomeric re-
gion, was calculated by measuring the chemiluminescent signal and the length of each TRF.
Telomerase Activity Assay
Telomerase activity was measured using TRAPeze RT Telomerase Detection kit (Millipore).
Cells were harvested, washed with PBS, resuspended in 200 μl of CHAPS lysis buffer (provided
in TRAPeze kit)/106 cells, and incubated on ice for 30 minutes. The samples were spun down
at 12,000 x g for 20 minutes at 4°C, 160 μl of supernatant was collected, protein concentration
determined with the BCA Protein Assay (Pierce), and the concentration of total protein was
normalized for each sample. The reaction mixture contained 5 μl 5X TRAPeze RT Reaction
Mix, 1 μl Taq polymerase (Titanium Taq, Clontech #639220), 17 μl nuclease free water, and
2 μl of TSR8 dilution (for standard curve), positive extract control, telomerase negative control,
no template control, experimental samples, or heat treated experimental samples. The parame-
ters for the qRT-PCR were 30 minutes at 30°C (1 cycle), 2 minutes at 95°C (1 cycle), and
then15 s at 94°C, 60 s at 59°C, 10 s at 45°C for 45 cycles using the primers are supplied by
the manufacturer.
SNP Genotyping
SNP Genotyping was performed on the OmniQuad version 1 (Illumina, Inc.), which interro-
gates 1,140,419 SNPs across the human genome. One μg input genomic DNA purified with the
DNeasy Blood & Tissue Kit (Qiagen) (the yield from approximately 200,000 cells) was ampli-
fied and labeled according to the manufacturer’s instructions. DNA was quantified using the
PicoGreen reagent (Life Technologies). Labeled product was then hybridized to the array and
scanned on a BeadArray Reader (Illumina, Inc.). Genotyping calls were made using BeadStudio
(Illumina, Inc.), using the standard cluster files provided by the manufacturer. The GenCall
threshold was set to 0.15, and the call rates were between 0.9911858 (EcmMech P147 D) and
0.9981838 (Control).
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Copy Number Variation Assessment
For the SNP Genotyping data, data preprocessing was performed in BeadScan (Illumina, Inc.).
Data cleaning, SNP calling, and replicate error identification was performed in GenomeStudio
(Illumina, Inc.). CNVPartition 3.2.0 [14] was used as the CNV-calling algorithm for calling du-
plications, with a CNV score threshold set at 50, and a minimum number of 10 SNPs per CNV
region. CNV locations are displayed according to the hg19/NCBI36 version of the human ge-
nome. We have previously shown that approximately 80% of the duplications called by this
method are validated by qPCR [3]. Since we previously found that only 40% of the regions of
deletion identified by CNVPartition were validated by qPCR [3], we required that regions of
deletion be identified both as regions of deletion by CNVPartition and as new regions of LOH
by replicate error analysis. All CNV calls were manually curated, and regions that were identi-
fied manually are indicated with a CNV Confidence Value designated as “NA”. Manual cura-
tion was also used to combine adjacent areas called by CNVPartition into larger regions of
CNV; in these cases, the CNV confidence interval is indicated as the range of CNV confidence
intervals calculated by CNVPartition for the encompassed subregions. During manual cura-
tion, we identified some regions of CNV that were present in only a subpopulation of cells,
which we termed “partial” duplications and deletions. We also identified some large regions of
partial CNV for which we could not determine with certainty whether they were partial dupli-
cations or partial deletions, and these we termed “Complex CNV.”
CNV-RT-PCR
Validation of the CNV values, obtained from CNVPartition 3.2.0., was done using TaqMan
Copy Number Assays (Life Technologies). The DNA used for validation was the same on
which SNP genotyping analysis was performed. The DNA was diluted in order to obtain a final
concentration of 5 ng/μl. 20 ng of DNA were loaded in the plate. Following the manufacturer’s
protocol, we prepared the reaction mixture (10 μl of TaqMan Genotyping Master Mix (Life
Technologies), 1 μl of probe of choice (Life Technologies), 1 μl of TaqMan Copy Number Ref-
erence Assay (Life Technologies), and 4 μl of nuclease free water) and added to each sample.
qPCR was performed using these cycling conditions: 10 minutes at 95°C (1 cycle), and then
15 s at 95°C, 60 s at 60°C, for 40 cycles. Six probes (three for the short arm and three for the
long arm of chromosome 12, Life Technologies)) were used to validate the CNV values of the
samples: Hs03295596_cn (12p11.22b chr12:29111191), Hs04404518_cn (12p11.21b
ch12:31250144), Hs03812366_cn (12p11.21b chr12:31944796), Hs03841181_cn (12q23.1b
chr12:979244490), Hs06947059_cn (12q24.11d chr12:111495082), and Hs06363301_cn
(12q24.23a chr12:118819770). The results were analyzed using the ΔΔCt method, using RNa-
seP as the control.
Gene Expression Microarray
Gene expression profiling was performed using HumanHT-12 v3 Expression BeadChips ac-
cording to the manufacturer’s instructions (Illumina, Inc.), with the exception of the definitive
mesoderm sample, for which gene expression profiling was performed using HumanHT-12 v4
BeadChips (Illumina, Inc.). Samples were prepared using the TotalPrep kit (Ambion, Inc.) ac-
cording to the manufacturer’s instructions. Probes were filtered with a detection-P value cut-
off of 0.05, and normalized using the LUMI package in R with the RSN (Robust spline
normalization) method.
Multivariate analysis was performed on all the undifferentiated samples using R. Different
variables were compared: time in culture (early vs. late), passage method (Enz vs. Mech), and
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substrate (Mef vs. Ecm). The output was filtered with a p-value cutoff of<0.01 and a fold-
change cutoff of>1.8.
Hierarchical clustering analysis was performed to determine the relative expression levels of
the pluripotency-associated genes using Cluster 3.0. The dendrograms and heatmaps were gen-
erated using Java Treeview [15].
Pathways analysis was performed with DAVID Bioinformatics Resources 6.7 [16].
DNAMethylation Microarray
DNA was extracted from 106 cells (Qiagen DNeasy kit) according to the manufacturer’s proto-
col and quantified using the Picogreen reagent (Life Technologies). Bisulfite conversion was
performed using the Bisulfite Conversion Kit from Zymo Research. Bisulfite converted DNA
was labeled and hybridized to Infinium HumanMethylation450 BeadChips (Illumina, Inc.),
scanned with an Illumina iScan BeadArray Scanner and quality controlled in GenomeStudio
(Illumina, Inc.). Pathway analysis was performed using GREAT [17], and visualized using
REVIGO [18].
Accession Numbers
The hESC DNAmethylation, gene expression, and SNP genotyping array data are available at
the NCBI GEO database under the accession designation GSE34982. The hiPSC SNP genotyp-
ing data are available under accession number GSE56834. The hESC and hiPSC DNAmethyla-
tion data are also available under SuperSeries GSE56851.
Results
We designed a highly replicated, combinatorial experiment to determine the effects of several
culture parameters on the long-term stability of hESC and hiPSC cultures. For the hESC exper-
iments, we received cryopreserved WA09 hESCs in WiCell medium at passage 28. The WA09
hESCs were derived (the first 6 passages) on mouse embryonic fibroblast (MEF) feeder layers
in basal medium with fetal bovine serum and human LIF; this was, followed by 22 passages in
standard hESC medium on MEFs. All passaging was done with collagenase [13].
After thawing the cells onto MEFs in standard hESC medium and passaging them mechani-
cally for 9 passages, the resulting passage 37 cells were used as the starting population of cells
for this study. We cultured the hESCs continuously for more than 100 additional passages
(nearly two years) in four different conditions, with six replicates per condition (Fig. 1 and S1
Table), which allowed us to distinguish the effects of two types of media (hESC medium with
Serum Replacement (see Materials and Methods) and defined medium (StemPro; Life Tech-
nologies, Inc.)), two substrates (feeder layer and extracellular matrix (Geltrex; Life Technolo-
gies, Inc.)), and two passaging methods (mechanical passage and enzymatic passage (Accutase;
Life Technologies, Inc.)). The passage numbers used throughout this manuscript are the num-
ber of passages after switching to the new culture conditions.
Each hESC culture was cryopreserved, tested for mycoplasma, and collected for molecular
analysis every 5 passages (Fig. 1B, S1 Table). Representative images showing typical cell mor-
phology in each culture condition were taken 5 passages after transitioning the cells into the
four different conditions (Fig. 1B). This was done shortly after placing the cells into the new
conditions to minimize the chance that differences in morphology would be due to genetic
changes. The hESCs cultured on MEF feeder layers with mechanical passaging (MefMech)
grew in large colonies with well-defined borders, while the hESCs on MEF feeder layers with
enzymatic passaging (MefEnz) grew in significantly smaller colonies, due to the fact that the
enzymatic passaging separated the cells into a single cell suspension. The hESCs cultured on a
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cell-free extracellular matrix grew in irregular clusters without defined borders (in contrast to
the cells cultured on MEFs), with the mechanically passaged cultures (EcmMech) having larger
clusters compared to the enzymatically passaged cultures (EcmEnz), consistent with the enzy-
matic dispersion of the cells into a single-cell suspension. Samples at selected passage numbers
Fig 1. Experimental design. A. Description of the four culture conditions used for the expansion of hESCWA09.B. Culture expansion and sample
collection strategy.
doi:10.1371/journal.pone.0118307.g001
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were analyzed for both global gene expression and SNP genotyping to assess genomic stability,
and DNA methylation profiling to monitor epigenetic stability. Cells in each condition were
also extensively phenotyped, including assays for cell proliferation, telomerase activity, apopto-
sis, pluripotency markers and differentiation capacity. These data have allowed us to determine
how differences in passage method, substrate, or medium type affect the hESCs.
For the hiPSC studies, the initial clones for the HDF51iPS1, HDF51iPS7, and HDF51iPS11
lines were first manually picked onto MEFs in standard hPSC medium and passaged mechani-
cally for 5–8 passages. We then sub-cultured each hiPSC line, maintaining one sub-culture in
the MefMech condition, and adapting one sub-culture to the EcmEnz condition. The cultures
were then passaged for an additional 25–35 passages in the two different conditions. The initial
cultures at passage 5–8, and the final cultures collected 25–35 passages later in the two different
conditions were analyzed using SNP genotyping with CNV calling to assess genomic stability.
Genetic Stability
For each of the four cell lines included in this study (one hESC line and three hiPSC lines), we
started with a single culture, and divided it into sub-cultures that were then carried in parallel
in different culture conditions (Fig. 1B). In this way, the cells from the original cultures could
serve as a baseline to identify genetic changes that occurred over the course of subsequent
long-term passage in the different culture conditions. SNP Genotyping and CNV calling were
performed on the original cultures to identify CNVs present at the start of the experiment
(S2A-B Table, “Original_MefMech” for the WA09 hESC line; S2C-E Table, “HDF51iPS1
Original_MefMech_P6”, “HDF51iPS7 Original_MefMech_P5”, “HDF51iPS11
Original_MefMech_P8”). The CNVs identified in the original cultures were subtracted from
the results from all later cultures, which allowed us to specifically identify de novo CNVs that
arose during the course of the experiment.
For the WA09 hESC line, the first round of SNP genotyping was performed on the original
culture, and cells cultured in the four conditions for ~40 passages and 103–161 passages be-
yond the initial 37 passages. For a subset of conditions, we performed additional SNP genotyp-
ing to better delineate the passage number at which de novo CNVs arose (S1 Table).
For the three hiPSC lines, SNP genotyping was performed on the initial passage 5–8 cul-
tures, and the MefMech and EcmEnz cultures collected 25–33 passages later.
Differences in Numbers of Genetic Aberrations in Different Conditions
In the hESC cultures, we compared the total number (Fig. 2A) and length (Fig. 2B) of duplica-
tions and deletions in each of the four culture conditions over time (see also Fig. 3A), as deter-
mined by SNP genotyping. Larger numbers of duplications were seen in the enzymatic passage
conditions (MefEnz and EcmEnz), suggesting that dissociation to single cells during passaging
might favor the accumulation of duplications. Between these two conditions, the MefEnz ap-
peared to be associated with larger duplications (Fig. 2B). In contrast, the mechanical passaging
conditions, MefMech and EcmMech, showed low numbers of duplications, most of which
arose at very late passage. The same trends held for deletions, with the MefEnz and EcmEnz
conditions showing higher frequencies of deletions, and the MefEnz condition showing the
largest number of deletions at higher passages. These data indicate that Accutase-based enzy-
matic passaging is associated with higher rates of genetic instability.
For the hiPSC studies, we focused on two conditions, MefMech and EcmEnz, and per-
formed our studies on one replicate each for three different hiPSC lines (Fig. 3B and S2C-E
Table). Two of the three hiPSC lines, HDF51iPS1 and HDF51iPS11, acquired a large aberration
in the EcmEnz condition. In HDF51iPS1, we observed a large region of LOH (loss of
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heterozygosity) on the long arm of chromosome 17, and in the HDF51iPS11 line, we observed
a large duplication on the short arm of chromosome 1. A small deletion developed in the
HDF51iPS11 line in the MefMech condition (Fig. 3B). This deletion encompassed 2 piRNAs
for which no specific functions have been identified (hsa_piR_005610 and hsa_piR_021822),
no identified protein-coding genes, no sequences marked by H3K27Ac (associated with active
enhancer sequences) in the WA01 hESC line in the ENCODE dataset (genome.ucsc.edu/
ENCODE/downloads.html), and no experimentally validated enhancer sequences listed in the
VISTA database (enhancer.lbl.gov). Although the hiPSC experiments were performed over a
relatively small number of passages (25–33 passages) and the total number of aberrations that
arose during the course of experiment was small, the hiPSC results are consistent with the
hESC results, which indicate that cells cultured in the EcmEnz condition accumulate larger ge-
netic aberrations at a higher frequency than those cultured in MefMech conditions.
Recurrent Duplications on Chromosomes 12 and 20 in the hESC
cultures
An overview of the regions of CNV that arose in the WA09 hESC line when cultured in differ-
ent conditions is shown in Fig. 3A (S2A-B Table). Since we acquired data at multiple time
points over the course of the experiment, we were able to follow the accumulation of genetic
aberrations. Most dramatically, we observed a duplication of a small segment of chromosome
20 in multiple cultures, which we have previously described as a region of recurrent duplication
among a large collection of hPSCs [3]. This duplication was observed after passage 40 in at
least one of the replicates in all of the conditions. Since the same duplication (with the same
Fig 2. Graphs illustrating the number (A) and total length (B) of genetic aberrations. Aberrations were identified in the samples using CNV analysis of
high resolution SNP genotyping data from the WA09 hESC line. Duplications and deletions; regions of loss of homozygosity (LOH) were categorized as
deletions and complex CNVs were categorized as duplications. The x-axis indicates the number of passages for the current study. All cultures started from a
source culture that had been passaged for 37 passages. Genetic aberrations present in this source culture were not counted, and therefore at the start of the
study, the number of duplications and deletions were set at 0. Of note, each culture condition was assigned a unique color that is consistent throughout
the manuscript.
doi:10.1371/journal.pone.0118307.g002
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Fig 3. Overview of genetic aberrations. Results are shown for theWA09 hESC line (A) and the HDF51IPS1, HDF51IPS7, and HDF51IPS11 hiPSC lines
(B). Fig. 3A shows regions of duplication and deletion in the 4culture conditions for the WA09 hESC line. Duplications (3 or 4 copies) (identified by
CNVPartition 3.2.0) are shown below the chromosome in a red scale. Deletions (0 or 1 copy) (identified by CNVPartition 3.2.0 and replicate error analysis)
are shown below the regions of duplication in a blue scale. Red and blue scales are used to represent the passage when the event (duplication or deletion)
first occurred, and they range from light colors (early passages) to darker colors (late passages). White and black hatches represent partial mutations
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start and end locations) appeared in multiple replicates in more than one condition, it is likely
that there was a small subpopulation of cells carrying this duplication within the original cell
population that was undetectable by our analysis methods. We also observed duplications on
chromosome 12 in the MefEnz condition (Fig. 3A; Fig. 4; S2A Table); recurrent duplications of
all or part this chromosome in hPSCs have also been described in other studies [3,19].
Recurrent Deletions on Chromosomes 17 Encompassing the TP53
gene in the hESC cultures
We also observed the accumulation of deletions, including deletions that arose in more than
one replicate of more than one condition (Fig. 3A; S2 Table). For the MefMech, EcmMech, and
EcmEnz conditions, the deletions appeared to be quite small, were detected after 40 passages,
and remained unchanged for the remainder of the experiment. For the MefEnz condition, the
number and length of deletions appeared to increase again in later passages.
Most strikingly, there were recurrent deletions on the short arm of chromosome 17 in four
replicates of MefEnz (at passage 41 for one replicate and at passage 104 for three replicates),
four replicates of EcmMech (at passage 147), and all six replicates of EcmEnz (at passage 41).
These deletions all overlapped within a 158 kb region (Fig. 5A), and were associated with de-
creased expression of three of the 17 genes located in this region, as measured using
HumanHT-12 BeadChip microarrays (Illumina). These three genes were SENP3 (SUMO1/
sentrin/SMT3 specific peptidase 3), SOX15 (SRY-BOX 15), and TP53 (P53), a well-known
tumor suppressor gene (Fig. 5B) [20]. Gene expression data for all of the genes in the deleted
region are shown in S1 Fig. (please note that some probes are located in regions where two or
three genes overlap, and that there are two probes each for CD68 and MPDU1).
It is notable that many of the observed deletions encompassing the TP53 gene had different
start/end positions, even among replicates of the same culture conditions (Fig. 3A; Fig. 5). This
suggests that several deletion events in this region arose independently and underwent positive
selection during the study.
Dynamic Genetic Aberrations over Time in Culture in the hESC Cultures
In a prior study, we observed dynamic shifts in subpopulations of cells within a culture, in
which one subpopulation was genetically normal and other subpopulations carried a given
CNV [3]. In this study, we again observed apparent gains and losses of specific genetic aberra-
tions over time in several of the hESC cultures. For example, in replicate A of the MefEnz con-
dition, a complete duplication of chromosome 12 appeared at passage 26, and was present at
passages 31 and 41, as detected by CNV analysis of SNP genotyping data (Fig. 4B). As verifica-
tion of the SNP genotyping results, we performed a qRT-PCR-based CNV assay on stored
DNA from the passage 41 culture (Fig. 4C), and thawed viable cryopreserved cells from passage
31, and after recovery from the thawing process performed karyotyping [47, XX, +12] at pas-
sage 36 (Fig. 4D). Between passages 41 and 85, the long arm was deleted and the short arm was
duplicated from one of the three copies of chromosome 12, resulting in the cells carrying
two copies of the long arm and four copies of the short arm of chromosome 12 (confirmed by
(duplications or deletions that are present in only a subpopulation of cells) and complex CNVs (CNVs that appear to be composed of both duplicated and
deleted regions, for which the precise copy numbers cannot confidently be called based on the SNP genotyping data), respectively. Asterisks represent
mutations that were present only in earlier passages and were not detectable in later passages. For each CNV in each condition, the replicate(s) in which the
event was detected is indicated by a letter to the right of each bar. Fig. 3B shows regions of duplication, deletion and LOH in the 2 culture conditions for the
hiPSC lines. Duplications are shown in blue, deletions are shown in red and regions of LOH are shown in green. The chromosome ideograms are from http://
genomics.energy.gov.
doi:10.1371/journal.pone.0118307.g003
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qRT-PCR on stored DNA from the passage 85 culture and karyotyping of cells cryopreserved
at passage 85 and recovered to passage 92 [47, XX, +i(12)(p10)]). Between passages 85 and 104,
the pattern again changed, this time to a complex CNV that is difficult to characterize based on
the BAF and LRR plots alone. We believe that this complex pattern arises from a mixed popu-
lation of cells, in which there are multiple subpopulations with different numerical abnormali-
ties for the p and q arms of chromosome 12.
In another example, we observed that a duplication of the short arm of chr12 in EcmEnz
culture A was seen in samples collected between passage 20 and passage 50, and then seemed
to disappear from the culture by passage 120 (Fig. 3A). As in our previous study [3], we attri-
bute this to mosaicism within cell cultures, which can result in changes of the proportion of
cells that carry a specific CNV over time. Since we analyzed bulk populations of cells, our re-
sults reflect the predominant state of the culture, rather than the individual cells in the culture.
Assays to Identify Phenotypic Differences in hESCs Associated with
Culture Conditions
To determine whether genomic differences would affect hESCs at the phenotypic level, we car-
ried out a set of assays aimed at quantifying cell proliferation, cell cycle distribution, telomerase
activity, telomere length, apoptosis, pluripotency, and differentiation capacity, after at least
50 passages in the assigned culture conditions (S1 Table). In contrast to the genotyping results,
Fig 4. Chromosome 12 detail in MefEnz.Detailed view of the duplications in chromosome 12 for MefEnz.A. The green areas indicate the regions of
duplication that were identified by CNVPartition 3.2.0. The areas that were detected manually rather than by the software are indicated in a scale from grey to
black. Estimates of the percentage of the population carrying the duplication were performed using the BAF distance for heterozygous SNPs as described
[3]. B. LogR Ratio (LRR) and BAF plots of replicate A of MefEnz showed changes in genetic aberrations over time.C. The CNV data were further validated
via TaqMan Copy Number Assays. Probe 1 corresponds to Hs03295596_cn, Probe 2 to Hs04404518_cn, Probe 3 to Hs03812366_cn, Probe 4 to
Hs03841181_cn, Probe 5 to Hs06947059_cn, and Probe 6 to Hs06363301_cn. D. Karyotyping results confirmed the CNV data.
doi:10.1371/journal.pone.0118307.g004
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Fig 5. Detail of recurrent deletions in chromosome 17. A. The short arm of the chromosome is enlarged
and the regions that showed deletions in the MefEnz, EcmMech, and EcmEnz conditions are indicated by red
bars. Blue lines enclose the common area among all the conditions and the genes in the common area are
indicated in the lower part of the figure. Genes for which the level of expression correlated with copy number
are highlighted by red squares.B. Graphs representing the expression levels of TP53, SENP3, and SOX15,
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which revealed clear patterns of recurrent genetic aberrations that corresponded to specific cul-
ture conditions, the results of the phenotypic assays were subtle.
To assess cell proliferation, we used the MTT assay, in addition to calculating doubling
times. Both assays indicated that enzymatic passaging was associated with higher proliferation
rates (Fig. 6A-B; S3 Table). Cell cycle distribution was determined by EdU incorporation and
quantitative DNA staining with Pacific Blue, followed by FACS analysis (Fig. 6C; S3 Table).
hESCs grown in the feeder-free conditions showed a higher level of EdU incorporation and a
larger proportion of cells in S phase (p<0.05).
Telomerase activity was quantified using the TRAP assay and telomere length was measured
by Southern blot using a digoxigenin-labeled probe (TeloTAGGG Telomere Length Assay)
(Fig. 6D-E; S3 Table). The results from these two assays were in agreement: hESCs in the Ecm-
Mech condition showed slightly lower telomerase activity and shortest telomere length com-
pared to the other conditions. We found no significant differences in the percentage of
apoptotic cells in the cultures using TUNEL-FACS (Roche) (Fig. 6F; S3 Table).
Overall, enzymatic passaging and feeder-free conditions were associated with a statistically
significantly higher proliferative rate and a statistically significantly higher percentage of cells
in S phase, but compared to the SNP genotyping results, the differences among culture condi-
tions according to these phenotypic assays were relatively minor.
Assessment of Pluripotency and Differentiation Capacity of hESCs in
Different Culture Conditions
The pluripotency of hESCs cultured in the four conditions was assessed by both expression of
pluripotency markers and a gene-expression based assay (PluriTest) [21]. Representative im-
ages showing the expression of the pluripotency markers OCT4/POU5F1 and SSEA4 by
immunocytochemistry are shown in S2A Fig., and indicate that both of these markers were
highly expressed in all four conditions after 40 passages. Using PluriTest, we showed that the
hESC samples from all four conditions fell well within the pluripotency space and could not be
distinguished from each other using this assay (S2B Fig.).
Differentiation capacity was determined using the embryoid body and teratoma assays. Rep-
resentative images from embryoid body differentiation experiments, demonstrating the ability
of cells from each condition to differentiate into every germ layer, are shown in S2C Fig. In the
teratoma assays, we quantified the percentage of cells from each germ layer for each tumor
(S2D-E Fig.; S4 Table). There were few significant differences in the proportion of derivatives
of ectoderm, mesoderm, and endoderm from cells cultured in the different conditions, other
than a lower proportion of endodermal derivatives in MefMech compared to EcmMech, and a
higher proportion of ectodermal derivatives in EcmEnz compared to MefMech (S2E Fig.; S4
Table).
Staining of teratoma sections with an anti-OCT4 antibody showed that persistence of OCT4
expression varied among the four culture conditions (Fig. 6G-H, S4 Table), with the highest
frequency of OCT4-positive foci found in the teratomas from the EcmEnz condition. A low fre-
quency of OCT4-positive foci were detected in teratomas from the MefEnz and EcmMech cul-
tures, and no OCT4-positive foci were found from the MefMech condition. These results
mirror the frequency of genetic aberrations found in the different conditions shown in Fig. 2A.
We specifically asked whether the number of OCT4-positive foci correlated with deletions of
as measured by gene expression microarray. The ideogram of the chromosome was from the U.S.
Department of Energy Genome Programs.
doi:10.1371/journal.pone.0118307.g005
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Fig 6. Phenotypic assays.Horizontal brackets indicate significant differences between the specified conditions, as calculated using ANOVA
(p-value<0.05). A. The MTT assay measures cell proliferation, with absorbance being correlated with cell growth.B. Doubling time was calculated from cell
counts taken over 3 days (average of 3 replicates per condition).C. The EdU incorporation was determined via FACS, and reveals the cell cycle distribution.
The graph shows the percent of cells in S phase.D. Relative telomerase activity is shown. E. Average number of telomere repeat fragments (TRF, average of
3 replicates) for each condition. F. Percent of apoptotic cells, determined using TUNEL-FACS.G. Example of an OCT4-positive focus in a teratoma section.
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the region of chromosome 17 including the TP53 gene described above, and found no signifi-
cant correlation. Persistent OCT4 expression after induction of differentiation is considered to
be an undesirable characteristic of in hPSC-derived cultures, as it may indicate a presence of re-
sidual pluripotent cells that are resistant to targeted differentiation and have a higher propensi-
ty for uncontrolled proliferation. These cells could lead to the generation of malignancies and/
or could differentiate into undesired cell types.
Differences in Genome-wide Gene Expression in hESCs Associated
with Time in Culture and Culture Method
We performed genome-wide gene expression profiling of all hESC replicates from the four cul-
ture conditions at early (passage 2–6) and late (passage 103–161) passage. We performed mul-
tivariate analysis, using time in culture (early vs. late), passage method (enzymatic vs.
mechanical), and substrate (MEF vs. ECM). We note that each substrate type was always used
with the same medium (MEF with serum replacement medium, and ECM with defined
medium).
We saw significant effects of time in culture on gene expression for all culture conditions
(Fig. 7A; S5A Table), although there were three clusters of genes for which the MefMech late
passage samples were more similar to the early passage samples (yellow boxes, Fig. 7A). We ob-
served very few effects dependent on the passage method (Fig. 7B; S5C Table) or substrate
(Fig. 7C; S5E Table). Pathway analysis, performed on genes differentially expressed over time
in culture, using DAVID identified significant changes (FDR<20%) in pathways associated
with TP53 signaling, apoptosis, and cancer (Fig. 7A; S5B Table). Mapping the expression levels
of the identified genes in the TP53 signaling pathway to a diagrammatic representation of the
KEGG pathway, we noted that the expression pattern was consistent with down-regulation in
TP53 function over time in culture (Fig. 7D). Inspecting the gene expression levels for these
genes at different passages in the four culture conditions, we observed that the differential ex-
pression between the early and late passages was most pronounced in conditions carrying a
TP53 deletion of in the late passages (MefEnz, EcmMech, and EcmEnz) (S8 Fig.). However, ex-
pression changes in the TP53 pathways were also seen in the condition in which deletions in
TP53 were not observed (in the MefMech condition), indicating that loss of function of TP53
may occur through epigenetic as well as genetic changes (S3 Fig.).
Differences in Genome-wide DNAMethylation of hESCs Associated
with Time in Culture and Culture Method
In parallel with the gene expression analysis, we performed genome-wide DNAmethylation
profiling of three hESC replicates from the four culture conditions at early (passages 5–6),
mid- (passages 41–42) and late (passages 103–161) passage. We examined X chromosome, im-
printed, and non-X/non-imprinted loci separately.
In earlier studies, we observed that low XIST (X (inactive)-specific transcript) expression is
associated with variable loss of DNA methylation on the X chromosome, and that approxi-
mately half of a large collection of female hPSC lines showed low XIST expression, including
the WA09 hESC line [22]. In addition, we have observed progressive loss of DNAmethylation
on the X chromosome with time in culture in hiPSCs that have low XIST expression [22].
H. Bar graph showing, for each culture condition, the percent of teratoma sections containing at least one OCT4-positive focus, and the average number of
foci per section. The error bar indicates the standard deviation of counts from 6 (EcmEnz), 7 (MefMech), or 8 (MefEnz and EcmMech) sections. Raw counts
can be found in S4 Table).
doi:10.1371/journal.pone.0118307.g006
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Fig 7. Differences in gene expression with time in culture, passagingmethod, andmedia type.Heatmaps showing differentially expressed genes for
early vs. late passage (A), mechanical vs. enzymatic passage (B), and Mef vs. Ecm substrate (C). In heatmap (A), the yellow boxes indicate genes for which
the expression levels in the late passage MefMech (P103) samples was similar to those in the early passage samples. Probes were selected by multivariate
regression. Enrichments in KEGG pathways identified by functional enrichment analysis are shown. Samples were arranged according to passage and
culture method, and hierarchical clustering was performed on the genes only.D. Diagram of the TP53 signaling pathway, showing genes downregulated in
the late vs. early passage samples, and the Ecm vs. Mef substrate comparisons.
doi:10.1371/journal.pone.0118307.g007
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Consistent with these observations, in the present study there was low expression of XIST and
focal absence of DNAmethylation in several regions of the X chromosome in all conditions at
all time-points (Fig. 8A; S6A Table). We also observed expansion of these regions at late pas-
sage in some, but not all, conditions. In fact, two regions on the X chromosome showed loss of
DNAmethylation associated with enzymatic passage (“Enz”) and with extracellular matrix
substrate (“Ecm”); we note that the EcmEnz condition samples showed loss of DNAmethyla-
tion in both of these regions. These results support the notion that the loss of XIST expression
at early passage is followed by gradual and progressive loss of DNA methylation on the X chro-
mosome, and that this can be influenced by culture conditions.
Genomic imprinting refers to monoallelic expression of specific genomic loci, which is con-
trolled in an epigenetic manner, and we have shown that imprinted gene expression changes
with time in culture of hPSCs [22]. Changes in DNAmethylation associated with culture con-
dition and time in culture were seen only for the NESP/GNAS complex locus, which showed
progressive loss of imprinting over time associated with the Mef substrate. Several alternative
transcripts arise from the NESP/GNAS complex locus due to usage of alternative transcription-
al initiation sites and alternative splice sites [23]. The loss of imprinting we observed consisted
of hypermethylation in an upstream cluster of CpGs and hypomethylation of a downstream
cluster (Fig. 8B; S6B Table).
On a global level, we saw significant effects of time in culture on DNAmethylation for all
culture conditions (Fig. 8C; S6C Table), although the MefMech late passage samples were simi-
lar to the early passage samples. We observed very few effects from passage method (Fig. 8D;
S6D Table) or substrate (Fig. 8E; S6E Table). Functional enrichment analysis for sets of DNA
methylation probes that showed coherent patterns of methylation was performed using
GREAT [17] (Fig. 8C-E, S6F-H Table).
Discussion
Given the high priority that has been placed on the development of hPSC-based therapies for
regenerative medicine, it is critical that we understand and appreciate the impact that the pro-
cedures used to manipulate the cells, including derivation, culture, and differentiation, can
have on their genetic and epigenetic stability. In this study, we focused on the effects of several
common variables during extended culture of hPSCs.
We report the results of a highly replicated study identifying the effects of different sub-
strates and passaging methods over extensive time in culture on genetic and epigenetic stability,
and phenotypic characteristics of hPSCs. In both hESCs and hiPSCs, we observed that enzy-
matic passaging on a feeder-free substrate was associated with an increased accumulation of ge-
netic aberrations compared to mechanical passaging on feeder layers. Long-term culturing of
hESCs showed that in the condition associated with the lowest overall rate of genetic aberration
(MefMech), the number of aberrations rose significantly only after passage 80 in our study
(which corresponded to a total passage number of 80+37 = 117). Detailed experiments in
hESCs suggested that the enzymatic passaging had a stronger effect on the accumulation of ge-
netic aberrations compared to the substrate.
We note that these findings may appear to be at odds with a portion of the results from our
earlier study, in which we did not observe correlations between passage number or method and
the number of aberrations [3]. However, it is important to appreciate the significant differences
in the design of the two studies, which are likely to account for the differences in the results. In
the earlier study, the hESC analysis was focused on understanding the degree of genetic insta-
bility for typical hESC cultures in established stem cell laboratories around the world, and was
essentially a cross-sectional survey of hESC cultures from several laboratories, each of which
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used their own culture and passage methods. Even when there were multiple samples for the
same hESC line, they were frequently collected from different labs using different methods at
different passage numbers, which may have obscured the effects of the individual variables on
genetic stability. In our earlier study, for the hiPSC analysis, the work was largely performed in
one laboratory using one set of culture and passage conditions [3]. Although we did not ob-
serve a significant difference in the total number of aberrations over time, we did note that de-
letions tended to occur during reprogramming and early passage, while duplications arose with
longer term passage. We saw a similar trend in newly derived hESC lines in a subsequent study
performed in collaboration with the laboratory of Dalit Ben-Yosef [24]. In contrast to the
Fig 8. DNAMethylation. A. X Chromosome DNAMethylation and XIST Expression. Methylation levels of genes in the X-chromosome (S6A Table) are
shown on the heatmap. Hierarchical clustering was performed on the samples, as indicated by the dendrogram. The genes are ordered according to their
location (from the beginning to the end of the chromosome). Samples that show loss of DNAmethylation for the “Enz” cluster are highlighted in blue, those
that show DNAmethylation for the “Ecm” cluster are highlighted in pink, and for both clusters in mauve. Genes located in the regions of loss of DNA
methylation are listed to the right of the heatmap. XIST expression is shown on the line graph, with the detection limit for the microarray indicated by the red
line. B. DNAmethylation at imprinted loci. Methylation levels for imprinted probes (S6B Table) are shown on the heatmap. Hierarchical clustering was
performed on the samples, as indicated by the dendrogram. The genes are ordered according to chromosome location; genes are listed to the left. The inset
at the right shows a detail of the NESP/GNAS complex locus, indicating the positions of the CpG sites that were hypermethylated (red triangle) vs.
hypomethylated (green triangle) in the late passage samples relative to the NESP/GNAS and NESPAS exons.C, D, E. Heatmaps showing differential DNA
methylation genes for early vs. late passage (C), mechanical vs. enzymatic passage (D), and Mef vs. Ecm substrate (E). In heatmap (C), the black boxes
indicate genes for which the DNAmethylation levels in the late passage MefMech (P103) samples was more similar to those in the early passage samples.
Probes were selected by multivariate regression. Functional enrichments identified by GREAT analysis are shown to the right of the heatmaps, visualized
using REVIGO [13]. Samples were arranged according to passage and culture method, and hierarchical clustering was performed on the genes only. In the
functional enrichment results, the size of the node indicated the number of contributing GO terms, and color of the nodes indicates the FDR (darker color for
lower FDR), and the edge length indicates the similarity between GO terms (shorter edge for more similar terms).
doi:10.1371/journal.pone.0118307.g008
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earlier study, this is a well-controlled and highly replicated longitudinal study performed in a
single lab, in which four hPSC lines were cultured for extended periods of time in four carefully
selected combinations of culture and passage conditions. This study design allowed us to ob-
serve that the number of CNVs was dependent on passage number, culture condition, and
passaging method.
In regard to specific aberrations seen in this study, we observed recurrent duplications of
chromosome 12 and chromosome 20q11 in multiple replicates and multiple conditions. Pres-
ence of a strong and specific selection pressure for duplications of these regions in hPSCs is
supported by several earlier reports showing duplications in the same regions [2–6,10,19]. We
saw duplications of chromosome 12 and chromosome 12p alone, but not chromosome 12q
alone. In fact, there was one culture in which a duplication of the entire chromosome 12 oc-
curred initially, followed by a loss of the extra copy of 12q. These findings support the conclu-
sion that there was positive selection for a specific sequence on chromosome 12p, and are
consistent with our previous results that identified a minimal area of duplication among several
different hESC lines that encompassed the expressed NANOG pseudogene NANOGP1 [3]. The
identification of the identical relatively small duplication on chromosome 20q11 in multiple
replicates of all four culture conditions in this study indicates that this duplication was likely
present in a small subset of cells in the original culture, particularly as different duplications en-
compassing this region have been described in many hPSC lines in prior studies [3,4], and
have recently been shown to confer a survival advantage to these cells [7]. Nguyen et al. showed
that hESCs with a gain of 20q11.21 had a 2.3-fold increase of Bcl-xL mRNA levels and a 3-fold
increase in the protein levels. The mutant hESC cultures underwent 2- to 3-fold less apoptosis
upon loss of cell-to-cell contact and were 2-fold more efficient in forming colonies from a sin-
gle cell when compared with wild type. Transgenic over-expression of BCL2L1 in the wild-type
cells led to apoptosis-resistant cells, and BCL2L1-knock-down in the mutant hESC, resulted in
a restoration of the wild-type phenotype. This resistance to apoptosis supposes a significant ad-
vantage for the mutant cells, explaining the high frequency of gains of 20q11.21 in hPSCs [7].
In terms of cellular phenotype, hESCs cultured in all four conditions were confirmed to be
pluripotent by immunocytochemistry for pluripotency markers, the PluriTest assay, in vitro
differentiation via embryoid body formation, and teratoma formation. Phenotypic assays mea-
suring cell proliferation, telomerase activity and telomere length, and apoptosis showed some
statistically significant differences among culture conditions, but these were overall not of prac-
tical consequence. We conclude that standard phenotypic assays are not sensitive enough to ge-
netic and epigenetic changes in hESC populations. OCT4 staining of teratoma sections did
reveal differences in the frequency of OCT4-positive foci in teratomas generated from cells
grown in the different culture conditions, with the highest frequency of OCT4-positive foci
from the EcmEnz cultures and no OCT4-positive foci from the MefMech cultures. It is rare for
experimental teratomas to retain OCT4-positive undifferentiated cells [25], and it is generally
assumed that the retention of undifferentiated cells is an indication of genetic aberrations and
that such tumors have a higher potential for metastatic malignancy. Since the EcmEnz condi-
tion produced more genetic abnormalities than the other conditions, the presence of undiffer-
entiated cells in the teratomas may be a manifestation of these aberrations.
Multivariate analysis of gene expression and DNAmethylation in the hESC cultures showed
significant effects from time in culture, with more modest effects attributable to passage meth-
od and substrate type. Genes in the TP53 pathway showed decreased expression with time in
culture and in cells cultured on the Ecm substrate, largely reflecting the deletion of the TP53
gene that occurred at late passage in all conditions except MefMech. The MefMech condition
showed the least change in DNAmethylation over time in culture, suggesting that this condi-
tion may be more favorable for epigenetic as well as genetic stability.
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Our results indicate dramatic differences in genetic and epigenetic stability and frequency of
persistent foci of OCT4-positive cells after teratoma formation among hPSCs cultured under
different conditions. Some, but not all, genetic aberrations we observed included recurrent du-
plications in genomic regions that we and others have identified as hotspots for duplications in
hPSCs in previous studies. Importantly, we observed for the first time recurrent deletion of the
genomic region containing the TP53 gene and consequent loss of expression of the TP53 tran-
script in hESCs. TP53 was first recognized to be a tumor suppressor gene in 1989 [20], and
since then, loss of TP53 function has been associated with many cancer types. The high fre-
quency of deletion of genomic regions encompassing the TP53 gene in hESC cultures suggest
that loss of TP53 function gives cells a selective advantage, allowing the abnormal cells to grad-
ually take over the cultures. We note that the deletions observed in our hESCs cultures were
single-copy deletions, indicating that even partial loss of TP53 expression may have significant
effects. Because loss of TP53 has been linked to uncontrolled cancerous growth, our observa-
tions highlight the need to monitor the genetic stability and expression levels of TP53 in popu-
lations of hPSCs destined for clinical use.
We recognize that use of different enzymatic passaging methods or media formulations
may yield different results. Specifically, we performed enzymatic passaging using Accutase,
which efficiently dissociates cells into a single-cell suspension, and thus our results may not
represent the stability of hPSCs passaged using collagenase or dispase, in which the cells remain
in clumps. Moreover, for our feeder-free cultures, we used StemPro media, which may yield
different results than the many other media formulations available today. However, our results
do conclusively demonstrate that marked differences in genetic stability, and more subtle dif-
ferences in cellular and molecular phenotype, are seen in hPSC cultures exposed to different
passage methods and culture conditions. For hPSC-based cell therapy to be feasible, it will be
necessary to produce large quantities of hPSCs, and thus it is notable that we found that two
conditions that are commonly used for large-scale expansion of hPSCs, feeder-free culture and
enzymatic passaging, were both associated with increased genetic and epigenetic instability.
Our study emphasizes the need to meticulously evaluate the effects of new media types, sub-
strates and passaging methods on the stability of hPSC cultures, particularly for cultures in-
tended for clinical use.
Supporting Information
S1 Fig. Gene expression in the chromosome 17 deleted region, as measured by gene expres-
sion microarray. Each set of graphs corresponds to one of the genes in the deleted region.
Each graph shows the expression level of the respective gene in each condition over time. The
red arrows indicate the conditions that carry the deletion. Please note that some probes are lo-
cated in regions where two or three genes overlap, and that there are two probes each for CD68
and MPDU1.
(TIF)
S2 Fig. Analysis of pluripotency and differentiation ability. A. Cells cultured in each condi-
tion expressed known pluripotency markers OCT4/POU5F1 and SSEA-4 (also stained with
DAPI). B. The PluriTest algorithm calculates a pluripotency score and a novelty score. Samples
for all conditions at early, middle and late passages are indicated by the colored dots. The red
cloud indicates the location of the pluripotent cells in the reference data set, and the blue clouds
indicate the location of the somatic cells from the reference data set [21]. C-E. The differentia-
tion ability of the conditions was shown in vitro with embryoid body formation (C) and in vivo
with teratoma formation (D-E). The embryoid bodies were stained with DAPI and the tissue
specific markers TUJ1, SOX2, SMA, T-Brachyury, AFP and GATA4. The tissues from the
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teratomas were identified using hemotoxylin and eosin staining. Percentages of the three germ
layers present in the teratomas were assessed visually. Curved lines and stars indicate signifi-
cant differences in percentages between culture conditions.
(TIF)
S3 Fig. Comparing substrates and media via gene expression. Diagram of the TP53 signaling
pathway, showing genes that were differentially expressed between the early and late passage
time points for each culture method. “Upregulated” indicates genes that were expressed at
higher levels at late passage (red), and “downregulated” indicates genes that were expressed at
lower levels at late passage (green). (A)MefMech, (B)MefEnz, (C) EcmMech, (D) EcmEnz.
(TIF)
S1 Table. Tables indicating the samples for the WA09 hESC line (culture condition and
passage number) on which each assay type was performed.
(XLSX)
S2 Table. Lists of all regions of duplication, deletion, LOH and complex CNV found in the
samples. A. Duplications and complex CNV for the WA09 hESC line. B. Deletions and regions
of LOH for the WA09 hESC line. C. Duplications for the hiPSC lines.D. Deletions for the
hiPSC lines. E. Regions of LOH for the hiPSC lines. The aberrations already present in the con-
trol culture (Original_MefMech) are reported separately and were excluded from the lists for
each condition. The first column corresponds to the cell line name. Column 2 includes condi-
tion name, passage number and replicate. The third column identifies the chromosome in
which the aberration occurred. The fourth and fifth columns indicate the start and the end po-
sitions of the aberration, respectively. The sixth column represents the copy number for each
aberration. The seventh column gives the confidence value of each call. If NA is indicated, it
means that the call was manually identified. The eighth column shows the length of the CNV.
Comments are written in the ninth column.
(XLSX)
S3 Table. Tables indicate the fold change and ANOVA p-values for each of the quantitative
phenotypic and differentiation assays. Significant p-values, (less than 0.05), are highlighted
in pink.
(XLSX)
S4 Table. Histopathologic and immunohistochemistry results from teratoma analysis. For
each culture condition, results are listed for all teratomas generated (some injections did not
yield teratomas). The cell culture replicate and animal numbers are indicated, as well as the
TP53 CNV status (deleted or not deleted). The weight of each teratoma is listed, as well as the
% of each section attributable to each germ layer by morphology, and the number of OCT4+
foci observed.
(XLSX)
S5 Table. Pathways analysis. Tables (A, C, E) show the lists of the gene expression probes that
were used for pathways analysis. Lists were derived from multivariate analysis according to the
variables time in culture (A), passage method (C), and substrate (E). Tables (B, D, F) show the
results obtained from the pathways analysis (filtered for FDR>20%) for time in culture (B),
passage method (D), and substrate (F).
(XLSX)
S6 Table. DNAmethylation tables. A. List of probes on the X chromosome that were partially
methylated in tissue samples and used for Fig. 8A. B. List of probes for imprinted genes that
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were partially methylated in tissue samples and used for Fig. 8B. Tables (C, D, E) list probes
that have differential DNA methylation according to the variables time in culture (C), passage
method (D), and substrate (E). Tables (F, G, H) list results from GREAT and REVIGO analy-
ses for time in culture (F), passage method (G), and substrate (H).
(XLSX)
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